查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595699

生物医药品安全性实验的全球市场:产业分析，规模，占有率，成长，趋势，预测(2024年～2031年)

Biologics Safety Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5个工作天内

价格
简介目录

重要考察

  • 生物製药安全测试市场规模：41.119 亿美元（2024 年）
  • 预计市值：86.086 亿美元（2031 年）
  • 全球市场成长率：11.1%（2024 年至 2031 年复合年增长率）

生物製药安全检测市场-报告范围

生物製药安全检测对于保障单株抗体、疫苗、基因治疗、细胞治疗等生物製药的安全性和有效性发挥重要作用。测试过程包括检测污染物、确认效力并确保生物製药符合监管要求。这些试验是在生物製药开发的各个阶段进行的，从早期研究到上市后监测。生物製药安全检测市场针对製药公司、生技公司、合约研究组织（CRO）和检测机构，提供内毒素检测、无菌检测、病毒安全检测等服务。

市场成长是由生物製药需求的增加、个人化医疗的扩张以及药物安全监管力度的加强所推动的。分析技术的进步，加上对病人安全和监管合规性的关注，持续加强生物製药安全测试市场。

市场推动因素

生物製药安全测试市场受到几个关键因素的推动，包括正在开发的生物製药数量不断增加，特别是针对慢性疾病、癌症和自体免疫疾病的生物製药。随着生物製药成为许多疾病的首选治疗方法，越来越需要全面的安全测试方案以确保其有效性和安全性。 FDA 和 EMA 等监管机构对生物製药测试制定了严格的指导方针，这推动了对高品质测试服务的需求。

此外，包括基因和细胞疗法在内的个人化医疗的兴起，需要专门的测试解决方案来确保这些治疗的安全性和有效性。新一代定序 (NGS) 和细胞检测等测试方法的创新透过提供更准确、更有效率的测试进一步推动市场成长。

市场限制因子

儘管成长前景广阔，但生物製药安全检测市场面临高检测成本的挑战，特别是对于基因治疗等新兴生物製药而言。这些治疗方法非常复杂，需要先进且昂贵的测试方法，这可能会限制预算有限的地区的使用。此外，生物製药漫长而复杂的审批流程可能会延迟新测试方法和技术的引入。

另一个挑战是生物製药安全检测领域缺乏熟练的专业人员，这可能会抑制该行业的扩张能力，以满足不断增长的检测服务需求。

市场机会

由于技术进步、策略联盟和不断扩大的药物管道，生物製药安全测试市场提供了巨大的成长机会。整合机器人和人工智慧等自动化测试系统可以提高安全测试方法的效率、准确性和成本效益。此外，对生物相似药的日益关注代表了一个新的细分市场，并需要进行测试以确保这些药物作为品牌生物製药的替代品的品质和安全性。

越来越多的公司正在聘请合约研究组织 (CRO) 来测试生物製药，特别是在生物製药需求不断增长的新兴经济体，现在是参与其中的好时机。透过投资研发并与生技公司结成策略联盟，测试实验室可以抓住新的机遇，并在不断发展的生物製药领域保持竞争力。

本报告提供全球生物医药品安全性测试市场调查分析，提供促进因素，趋势，课题，未来的机会等详细分析。

目录

第1章 摘要整理

第2章 全球生物医药品安全性测试市场概要

    • 全球生物医药品安全性测试市场的分类
    • 全球生物医药品安全性测试市场定义
  • 全球生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 全球生物医药品安全性测试市场的与前一年同期比较成长
  • 全球生物医药品安全性实验的市场动态
  • 供应链
  • 成本结构
  • 价格分析
  • 原料筹资策略与分析
  • 供应商清单
  • 主要加入企业的市场影响(强度地图):各地区

第3章 全球生物医药品安全性测试市场的分析与预测:各产品类型

  • 全球生物医药品安全性实验的市场规模与预测:各产品类型(2024年～2031年)
    • 套件·试剂的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 器具的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 服务的生物医药品安全性实验的市场规模与预测(2024年～2031年)

第4章 全球生物医药品安全性测试市场的分析与预测:各实验类型

  • 全球生物医药品安全性实验的市场规模预测:各实验类型(2024年～2031年)
    • 终局毒素实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 无菌实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 细胞株认证，特性评估实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 余留宿主污染检测实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 外来性病原体检测实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 微生物附着量实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 其他的实验的生物医药品安全性实验的市场规模与预测(2024年～2031年)

第5章 全球生物医药品安全性测试市场的分析与预测:各用途

  • 全球生物医药品安全性实验的市场规模与预测:各用途(2024年～2031年)
    • 疫苗·开发治疗生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 血液·血液相关产品实验生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 细胞·基因治疗生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 组织·组织相关产品实验生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 干细胞研究生物医药品安全性实验的市场规模与预测(2024年～2031年)

第6章 全球生物医药品安全性测试市场的分析与预测:各地区

  • 全球生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 北美的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 南美的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 欧洲的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 日本的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 亚太地区(日本以外)的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 中东·非洲的生物医药品安全性实验的市场规模与预测(2024年～2031年)

第7章 北美的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • 美国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 加拿大的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第8章 南美的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • 巴西的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 墨西哥的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 阿根廷的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第9章 欧洲的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • 德国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 英国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 法国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 西班牙的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 义大利的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 北欧的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第10章 日本的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • 日本的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第11章 亚太地区(日本以外)的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • 中国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 印度的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 马来西亚的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 泰国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 新加坡的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 澳洲的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第12章 中东·非洲的生物医药品安全性测试市场的分析与预测:各国(2024年～2031年)

  • GCC各国的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 南非的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 奈及利亚的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途
  • 以色列的生物医药品安全性实验的市场规模与预测(2024年～2031年)
    • 收益的比较:各产品类型
    • 收益的比较:各实验类型
    • 收益的比较:各用途

第13章 全球生物医药品安全性测试市场的企业占有率，竞争情形，企业简介

  • Competition Landscape
    • Charles River Laboratories International, Inc.
    • Eurofins Scientific Se
    • SGS S.A.
    • Thermo Fisher Scientific Inc.
    • Genscript
    • Biomerieux Sa
    • Pace Analytical Services Inc.
    • Lonza Group Ltd.
    • Toxikon Corporation
    • Wuxi Apptec

第14章 调查手法

第15章 第二手资料和第一手资料

第16章 前提条件与缩写

第17章 免责声明

简介目录
Product Code: PMRREP18592

Persistence Market Research has recently released a comprehensive report on the worldwide market for biologics safety testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global biologics safety testing market from 2024 to 2031.

Key Insights:

  • Biologics Safety Testing Market Size (2024E): USD 4111.9 Million
  • Projected Market Value (2031F): USD 8608.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 11.1%

Biologics Safety Testing Market - Report Scope:

Biologics safety testing plays a critical role in ensuring the safety and efficacy of biologic drugs, including monoclonal antibodies, vaccines, gene therapies, and cell-based therapies. The testing process involves detecting contaminants, verifying potency, and ensuring that biologics meet regulatory requirements. These tests are conducted at various stages of biologic development, from early-phase research to post-marketing surveillance. The biologics safety testing market caters to pharmaceutical and biotechnology companies, contract research organizations (CROs), and testing laboratories, providing services such as endotoxin testing, sterility testing, and viral safety testing.

Market growth is driven by the increasing demand for biologics, the expansion of personalized medicine, and growing regulatory scrutiny surrounding drug safety. Advances in analytical technologies, coupled with the rising emphasis on patient safety and regulatory compliance, continue to bolster the biologics safety testing market.

Market Growth Drivers:

The biologics safety testing market is propelled by several key factors, including the growing number of biologic drugs in development, especially for chronic diseases, cancer, and autoimmune disorders. With biologics becoming a preferred treatment for many diseases, there is an increasing need for comprehensive safety testing protocols to ensure their effectiveness and safety. Regulatory agencies like the FDA and EMA are imposing stricter guidelines on biologic testing, which drives the demand for high-quality testing services.

Moreover, the rise of personalized medicine, which includes gene and cell-based therapies, has created a need for specialized testing solutions to ensure these treatments' safety and efficacy. Innovations in testing methodologies, such as next-generation sequencing (NGS) and cell-based assays, further support market growth by providing more accurate and efficient testing.

Market Restraints:

Despite promising growth prospects, the biologics safety testing market faces challenges related to the high costs of testing, especially for emerging biologics like gene therapies. The complexity of these treatments requires advanced and expensive testing methods, which could limit access in regions with budget constraints. Additionally, the lengthy and complex regulatory approval process for biologics may delay the introduction of new testing methods and technologies.

Another challenge is the shortage of skilled professionals in the field of biologics safety testing, which can hinder the industry's ability to scale up operations to meet the growing demand for testing services.

Market Opportunities:

The biologics safety testing market presents significant growth opportunities driven by technological advancements, strategic partnerships, and an expanding drug pipeline. The integration of automated testing systems, such as robotics and artificial intelligence (AI), can improve efficiency, accuracy, and cost-effectiveness in safety testing procedures. Additionally, the rising focus on biosimilars presents a new market segment, requiring testing to ensure the quality and safety of these alternatives to branded biologics.

The increasing adoption of contract research organizations (CROs) for biologics testing presents an opportunity for industry players to enter new markets and regions, particularly in developing economies where the demand for biologics is rising. By investing in research and development and forming strategic alliances with biotechnology companies, testing laboratories can tap into emerging opportunities and stay competitive in the evolving biologics landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the biologics safety testing market globally?
  • Which testing methods are most widely adopted for biologics safety testing, and how are they evolving?
  • How are advancements in testing technologies reshaping the competitive landscape of the biologics safety testing market?
  • Who are the key players contributing to the biologics safety testing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global biologics safety testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global biologics safety testing market, such as Charles River Laboratories, Lonza Group, and WuXi AppTec, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop advanced testing solutions that are faster, more accurate, and cost-effective. Collaborations with pharmaceutical companies, CROs, and regulatory bodies enhance market access and promote the adoption of state-of-the-art testing services.

Furthermore, market players emphasize regulatory compliance, patient safety, and technological advancements as critical strategies to enhance their market position. These efforts are expected to fuel market growth and lead to improvements in biologics safety testing standards.

Key Companies Profiled:

  • Charles River Laboratories
  • Lonza Group
  • WuXi AppTec
  • Merck KGaA
  • Q2 Solutions
  • BioReliance (Merck)
  • Eurofins Scientific
  • Labcorp Drug Development
  • Intertek Group
  • Ecolab

Market Segmentation:

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Product Type

  • Kits & Reagents
  • Instruments
  • Services

Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Adventitious Agent Detection Tests
  • Bioburden Tests
  • Other Tests

Application

  • Vaccine and Therapeutics Development
  • Blood and Blood-related Products Testing
  • Cellular and Gene Therapy
  • Tissue-related Products Testing
  • Stem Cell Research

Table of Contents

1. Executive Summary

2. Global Biologics Safety Testing Market Overview

  • 2.1. Introduction
    • 2.1.1. Global Biologics Safety Testing Market Taxonomy
    • 2.1.2. Global Biologics Safety Testing Market Definition
  • 2.2. Global Biologics Safety Testing Market Size (US$ Mn) and Forecast, 2024-2031
    • 2.2.1. Global Biologics Safety Testing Market Y-o-Y Growth
  • 2.3. Global Biologics Safety Testing Market Dynamics
  • 2.4. Supply Chain
  • 2.5. Cost Structure
  • 2.6. Pricing Analysis
  • 2.7. Raw Material Sourcing Strategy and Analysis
  • 2.8. Supplier List
  • 2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Biologics Safety Testing Market Analysis and Forecast By Product Type

  • 3.1. Global Biologics Safety Testing Market Size and Forecast By Product Type, 2024-2031
    • 3.1.1. Kits & Reagents Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 3.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 3.1.1.2. Market Share Comparison, By Region
      • 3.1.1.3. Y-o-Y growth Comparison, By Region
    • 3.1.2. Instruments Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 3.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 3.1.2.2. Market Share Comparison, By Region
      • 3.1.2.3. Y-o-Y growth Comparison, By Region
    • 3.1.3. Services Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 3.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 3.1.3.2. Market Share Comparison, By Region
      • 3.1.3.3. Y-o-Y growth Comparison, By Region

4. Global Biologics Safety Testing Market Analysis and Forecast By Test Type

  • 4.1. Global Biologics Safety Testing Market Size and Forecast By Test Type, 2024-2031
    • 4.1.1. Endotoxin Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Sterility Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Cell Line Authentication and Characterization Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
    • 4.1.4. Residual Host Contamination Detection Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.4.2. Market Share Comparison, By Region
      • 4.1.4.3. Y-o-Y growth Comparison, By Region
    • 4.1.5. Adventitious Agent Detection Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.5.2. Market Share Comparison, By Region
      • 4.1.5.3. Y-o-Y growth Comparison, By Region
    • 4.1.6. Bioburden Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.6.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.6.2. Market Share Comparison, By Region
      • 4.1.6.3. Y-o-Y growth Comparison, By Region
    • 4.1.7. Other Tests Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 4.1.7.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.7.2. Market Share Comparison, By Region
      • 4.1.7.3. Y-o-Y growth Comparison, By Region

5. Global Biologics Safety Testing Market Analysis and Forecast By Application

  • 5.1. Global Biologics Safety Testing Market Size and Forecast By Application, 2024-2031
    • 5.1.1. Vaccine and Therapeutics Development Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 5.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 5.1.1.2. Market Share Comparison, By Region
      • 5.1.1.3. Y-o-Y growth Comparison, By Region
    • 5.1.2. Blood and Blood-related Products Testing Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 5.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 5.1.2.2. Market Share Comparison, By Region
      • 5.1.2.3. Y-o-Y growth Comparison, By Region
    • 5.1.3. Cellular and Gene Therapy Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 5.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 5.1.3.2. Market Share Comparison, By Region
      • 5.1.3.3. Y-o-Y growth Comparison, By Region
    • 5.1.4. Tissue and Tissue-related Products Testing Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 5.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 5.1.4.2. Market Share Comparison, By Region
      • 5.1.4.3. Y-o-Y growth Comparison, By Region
    • 5.1.5. Stem Cell Research Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 5.1.5.1. Revenue (US$ Mn) Comparison, By Region
      • 5.1.5.2. Market Share Comparison, By Region
      • 5.1.5.3. Y-o-Y growth Comparison, By Region

6. Global Biologics Safety Testing Market Analysis and Forecast By Region

  • 6.1. Global Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 6.1.1. North America Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.1.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.1.3. Revenue (US$ Mn) Comparison, By Application
    • 6.1.2. Latin America Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.2.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.2.3. Revenue (US$ Mn) Comparison, By Application
    • 6.1.3. Europe Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.3.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.3.3. Revenue (US$ Mn) Comparison, By Application
    • 6.1.4. Japan Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.4.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.4.3. Revenue (US$ Mn) Comparison, By Application
    • 6.1.5. APEJ Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.5.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.5.3. Revenue (US$ Mn) Comparison, By Application
    • 6.1.6. MEA Biologics Safety Testing Market Size and Forecast, 2024-2031
      • 6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type
      • 6.1.6.2. Revenue (US$ Mn) Comparison, By Test Type
      • 6.1.6.3. Revenue (US$ Mn) Comparison, By Application

7. North America Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 7.1. US Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 7.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 7.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 7.1.3. Revenue (US$ Mn) Comparison, By Application
  • 7.2. Canada Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 7.2.1. Revenue (US$ Mn) Comparison, By Product Type
    • 7.2.2. Revenue (US$ Mn) Comparison, By Test Type
    • 7.2.3. Revenue (US$ Mn) Comparison, By Application

8. Latin America Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 8.1. Brazil Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 8.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 8.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 8.1.3. Revenue (US$ Mn) Comparison, By Application
  • 8.2. Mexico Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 8.2.1. Revenue (US$ Mn) Comparison, By Product Type
    • 8.2.2. Revenue (US$ Mn) Comparison, By Test Type
    • 8.2.3. Revenue (US$ Mn) Comparison, By Application
  • 8.3. Argentina Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 8.3.1. Revenue (US$ Mn) Comparison, By Product Type
    • 8.3.2. Revenue (US$ Mn) Comparison, By Test Type
    • 8.3.3. Revenue (US$ Mn) Comparison, By Application

9. Europe Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 9.1. Germany Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.1.3. Revenue (US$ Mn) Comparison, By Application
  • 9.2. UK Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.2.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.2.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.2.3. Revenue (US$ Mn) Comparison, By Application
  • 9.3. France Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.3.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.3.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.3.3. Revenue (US$ Mn) Comparison, By Application
  • 9.4. Spain Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.4.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.4.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.4.3. Revenue (US$ Mn) Comparison, By Application
  • 9.5. Italy Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.5.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.5.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.5.3. Revenue (US$ Mn) Comparison, By Application
  • 9.6. Nordic Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 9.6.1. Revenue (US$ Mn) Comparison, By Product Type
    • 9.6.2. Revenue (US$ Mn) Comparison, By Test Type
    • 9.6.3. Revenue (US$ Mn) Comparison, By Application

10. Japan Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 10.1. Japan Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 10.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 10.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 10.1.3. Revenue (US$ Mn) Comparison, By Application

11. APEJ Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 11.1. China Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.1.3. Revenue (US$ Mn) Comparison, By Application
  • 11.2. India Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.2.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.2.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.2.3. Revenue (US$ Mn) Comparison, By Application
  • 11.3. Malaysia Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.3.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.3.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.3.3. Revenue (US$ Mn) Comparison, By Application
  • 11.4. Thailand Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.4.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.4.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.4.3. Revenue (US$ Mn) Comparison, By Application
  • 11.5. Singapore Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.5.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.5.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.5.3. Revenue (US$ Mn) Comparison, By Application
  • 11.6. Australia Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 11.6.1. Revenue (US$ Mn) Comparison, By Product Type
    • 11.6.2. Revenue (US$ Mn) Comparison, By Test Type
    • 11.6.3. Revenue (US$ Mn) Comparison, By Application

12. MEA Biologics Safety Testing Market Analysis and Forecast, By Country, 2024-2031

  • 12.1. GCC Countries Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 12.1.1. Revenue (US$ Mn) Comparison, By Product Type
    • 12.1.2. Revenue (US$ Mn) Comparison, By Test Type
    • 12.1.3. Revenue (US$ Mn) Comparison, By Application
  • 12.2. South Africa Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 12.2.1. Revenue (US$ Mn) Comparison, By Product Type
    • 12.2.2. Revenue (US$ Mn) Comparison, By Test Type
    • 12.2.3. Revenue (US$ Mn) Comparison, By Application
  • 12.3. Nigeria Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 12.3.1. Revenue (US$ Mn) Comparison, By Product Type
    • 12.3.2. Revenue (US$ Mn) Comparison, By Test Type
    • 12.3.3. Revenue (US$ Mn) Comparison, By Application
  • 12.4. Israel Biologics Safety Testing Market Size and Forecast, 2024-2031
    • 12.4.1. Revenue (US$ Mn) Comparison, By Product Type
    • 12.4.2. Revenue (US$ Mn) Comparison, By Test Type
    • 12.4.3. Revenue (US$ Mn) Comparison, By Application

13. Global Biologics Safety Testing Market Company Share, Competition Landscape and Company Profiles

  • 13.1. Company Share Analysis
  • 13.2. Competition Landscape
  • 13.3. Company Profiles
    • 13.3.1. Charles River Laboratories International, Inc.
    • 13.3.2. Eurofins Scientific Se
    • 13.3.3. SGS S.A.
    • 13.3.4. Thermo Fisher Scientific Inc.
    • 13.3.5. Genscript
    • 13.3.6. Biomerieux Sa
    • 13.3.7. Pace Analytical Services Inc.
    • 13.3.8. Lonza Group Ltd.
    • 13.3.9. Toxikon Corporation
    • 13.3.10. Wuxi Apptec

14. Research Methodology

15. Secondary and Primary Sources

16. Assumptions and Acronyms

17. Disclaimer